{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:59:59Z","timestamp":1780459199246,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T00:00:00Z","timestamp":1636243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10741-021-10183-w","type":"journal-article","created":{"date-parts":[[2021,11,7]],"date-time":"2021-11-07T03:02:38Z","timestamp":1636254158000},"page":"1531-1541","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The utility of positron emission tomography in cardiac amyloidosis"],"prefix":"10.1007","volume":"27","author":[{"given":"Subha","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Michel","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ibrahim","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushui","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2348-0484","authenticated-orcid":false,"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,7]]},"reference":[{"issue":"6","key":"10183_CR1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349(6):583\u2013596","journal-title":"N Engl J Med"},{"issue":"19","key":"10183_CR2","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","volume":"98","author":"D Phelan","year":"2012","unstructured":"Phelan D et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98(19):1442\u20131448","journal-title":"Heart"},{"issue":"2","key":"10183_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","volume":"3","author":"IS Syed","year":"2010","unstructured":"Syed IS et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3(2):155\u2013164","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10183_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/ajh.20745","volume":"82","author":"AV Kristen","year":"2007","unstructured":"Kristen AV, Dengler TJ, Katus HA (2007) Suspected cardiac amyloidosis: endomyocardial biopsy remains the diagnostic gold-standard. Am J Hematol 82(4):328","journal-title":"Am J Hematol"},{"issue":"3","key":"10183_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","volume":"7","author":"RH Falk","year":"2014","unstructured":"Falk RH, Quarta CC, Dorbala S (2014) How to image cardiac amyloidosis. Circ Cardiovasc Imaging 7(3):552\u2013562","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10183_CR6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jacc.2019.11.037","volume":"75","author":"SP Lee","year":"2020","unstructured":"Lee SP et al (2020) Pittsburgh B compound positron emission tomography in patients with AL cardiac amyloidosis. J Am Coll Cardiol 75(4):380\u2013390","journal-title":"J Am Coll Cardiol"},{"issue":"10038","key":"10183_CR7","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN (2016) Systemic amyloidosis. Lancet 387(10038):2641\u20132654","journal-title":"Lancet"},{"key":"10183_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pharmthera.2017.06.011","volume":"180","author":"KM Alexander","year":"2017","unstructured":"Alexander KM, Singh A, Falk RH (2017) Novel pharmacotherapies for cardiac amyloidosis. Pharmacol Ther 180:129\u2013138","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10183_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","volume":"46","author":"E Perugini","year":"2005","unstructured":"Perugini E et al (2005) Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 46(6):1076\u20131084","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10183_CR10","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"Ruberg FL et al (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73(22):2872\u20132891","journal-title":"J Am Coll Cardiol"},{"issue":"38","key":"10183_CR11","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1093\/eurheartj\/ehv328","volume":"36","author":"A Casta\u00f1o","year":"2015","unstructured":"Casta\u00f1o A, Bokhari S, Maurer MS (2015) Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction. Eur Heart J 36(38):2595\u20132597","journal-title":"Eur Heart J"},{"issue":"24","key":"10183_CR12","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"Gillmore JD et al (2016) Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 133(24):2404\u20132412","journal-title":"Circulation"},{"issue":"6","key":"10183_CR13","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","volume":"26","author":"S Dorbala","year":"2019","unstructured":"Dorbala S et al (2019) ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2\u2014evidence base and standardized methods of imaging. J Nucl Cardiol 26(6):2065\u20132123","journal-title":"J Nucl Cardiol"},{"issue":"6","key":"10183_CR14","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","volume":"13","author":"S Rosengren","year":"2020","unstructured":"Rosengren S et al (2020) Diagnostic accuracy of [11C]PIB positron emission tomography for detection of cardiac amyloidosis. JACC Cardiovasc Imaging 13(6):1337\u20131347","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10183_CR15","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","volume":"13","author":"SAM Cuddy","year":"2020","unstructured":"Cuddy SAM et al (2020) Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease? JACC Cardiovasc Imaging 13(6):1325\u20131336","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10183_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","volume":"23","author":"A Casta\u00f1o","year":"2016","unstructured":"Casta\u00f1o A et al (2016) Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 23(6):1355\u20131363","journal-title":"Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology"},{"issue":"3","key":"10183_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE et al (2004) Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh compound-B. Ann Neurol 55(3):306\u2013319","journal-title":"Ann Neurol"},{"issue":"2","key":"10183_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2967\/jnumed.111.102053","volume":"54","author":"G Antoni","year":"2013","unstructured":"Antoni G et al (2013) In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET. J Nucl Med 54(2):213\u2013220","journal-title":"J Nucl Med"},{"issue":"3","key":"10183_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00259-017-3814-1","volume":"45","author":"N Ezawa","year":"2018","unstructured":"Ezawa N et al (2018) Visualization of multiple organ amyloid involvement in systemic amyloidosis using (11)C-PiB PET imaging. Eur J Nucl Med Mol Imaging 45(3):452\u2013461","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10183_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","volume":"8","author":"SP Lee","year":"2015","unstructured":"Lee SP et al (2015) 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging 8(1):50\u201359","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10183_CR21","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jacc.2016.04.035","volume":"68","author":"AV Kristen","year":"2016","unstructured":"Kristen AV et al (2016) Cardiac amyloid load: a prognostic and predictive biomarker in patients with light-chain amyloidosis. J Am Coll Cardiol 68(1):13\u201324","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10183_CR22","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12350-016-0638-5","volume":"25","author":"B Pilebro","year":"2018","unstructured":"Pilebro B et al (2018) Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR). J Nucl Cardiol 25(1):240\u2013248","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10183_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","volume":"63","author":"H Koike","year":"2004","unstructured":"Koike H et al (2004) Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63(1):129\u2013138","journal-title":"Neurology"},{"issue":"4","key":"10183_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/13506129.2020.1798223","volume":"27","author":"K Takasone","year":"2020","unstructured":"Takasone K et al (2020) Non-invasive detection and differentiation of cardiac amyloidosis using (99m)Tc-pyrophosphate scintigraphy and (11)C-Pittsburgh compound B PET imaging. Amyloid 27(4):266\u2013274","journal-title":"Amyloid"},{"issue":"6","key":"10183_CR25","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","volume":"13","author":"S Rosengren","year":"2020","unstructured":"Rosengren S et al (2020) Diagnostic accuracy of [(11)C]PIB positron emission tomography for detection of cardiac amyloidosis. JACC Cardiovasc Imaging 13(6):1337\u20131347","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"10183_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/WAD.0b013e31821300bc","volume":"26","author":"SR Choi","year":"2012","unstructured":"Choi SR et al (2012) Correlation of amyloid PET ligand florbetapir F 18 binding with A\u03b2 aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord 26(1):8\u201316","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"10183_CR27","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/brain\/awt142","volume":"136","author":"R Ni","year":"2013","unstructured":"Ni R et al (2013) Amyloid tracers detect multiple binding sites in Alzheimer\u2019s disease brain tissue. Brain 136(7):2217\u20132227","journal-title":"Brain"},{"issue":"8","key":"10183_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol 11(8):669\u2013678","journal-title":"Lancet Neurol"},{"key":"10183_CR29","doi-asserted-by":"crossref","unstructured":"Park MA et al (2015)\u00a018F-Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study. Circ Cardiovasc Imag\u00a08(8)","DOI":"10.1161\/CIRCIMAGING.114.002954"},{"key":"10183_CR30","doi-asserted-by":"crossref","unstructured":"Dorbala S et al (2014) Imaging cardiac amyloidosis: a pilot study using 18F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging 41(9):1652-1662","DOI":"10.1007\/s00259-014-2787-6"},{"key":"10183_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","volume":"2","author":"DR Osborne","year":"2015","unstructured":"Osborne DR et al (2015) A routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using (18)F-florbetapir. Front Cardiovasc Med 2:23","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10183_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1080\/13506129.2018.1552852","volume":"25","author":"R Manwani","year":"2018","unstructured":"Manwani R et al (2018) A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement. Amyloid 25(4):247\u2013252","journal-title":"Amyloid"},{"issue":"1","key":"10183_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13550-018-0425-1","volume":"8","author":"L Baratto","year":"2018","unstructured":"Baratto L et al (2018) (18)F-Florbetaben whole-body PET\/MRI for evaluation of systemic amyloid deposition. EJNMMI Res 8(1):66","journal-title":"EJNMMI Res"},{"issue":"11","key":"10183_CR34","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","volume":"57","author":"WP Law","year":"2016","unstructured":"Law WP et al (2016) Cardiac amyloid imaging with 18F-florbetaben PET: a pilot study. J Nucl Med 57(11):1733\u20131739","journal-title":"J Nucl Med"},{"issue":"7","key":"10183_CR35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","volume":"46","author":"M Kircher","year":"2019","unstructured":"Kircher M et al (2019) Detection of cardiac amyloidosis with (18)F-florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy. Eur J Nucl Med Mol Imaging 46(7):1407\u20131416","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10183_CR36","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1097\/RLU.0000000000002699","volume":"44","author":"M Seo","year":"2019","unstructured":"Seo M et al (2019) Clinical utility of 18F-florbetaben PET for detecting amyloidosis associated with multiple myeloma: a prospective case-control study. Clin Nucl Med 44(9):e503\u2013e509","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10183_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","volume":"14","author":"D Genovesi","year":"2021","unstructured":"Genovesi D et al (2021) [18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions. JACC Cardiovasc Imaging 14(1):246\u2013255","journal-title":"JACC Cardiovasc Imaging"},{"issue":"4","key":"10183_CR38","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12350-015-0287-0","volume":"23","author":"A Van Der Gucht","year":"2016","unstructured":"Van Der Gucht A et al (2016) [18F]-NaF PET\/CT imaging in cardiac amyloidosis. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 23(4):846\u2013849","journal-title":"Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology"},{"issue":"2","key":"10183_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s12350-016-0457-8","volume":"24","author":"C Gagliardi","year":"2017","unstructured":"Gagliardi C et al (2017) Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET\/CT? Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 24(2):746\u2013749","journal-title":"Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology"},{"issue":"5","key":"10183_CR40","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s12350-017-0799-x","volume":"25","author":"R Morgenstern","year":"2018","unstructured":"Morgenstern R et al (2018) 18Fluorine sodium fluoride positron emission tomography, a potential biomarker of transthyretin cardiac amyloidosis. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 25(5):1559\u20131567","journal-title":"Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology"},{"issue":"24","key":"10183_CR41","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1016\/j.jacc.2016.09.953","volume":"68","author":"MG Trivieri","year":"2016","unstructured":"Trivieri MG et al (2016) (18)F-Sodium fluoride PET\/MR for the assessment of cardiac amyloidosis. J Am Coll Cardiol 68(24):2712\u20132714","journal-title":"J Am Coll Cardiol"},{"key":"10183_CR42","doi-asserted-by":"crossref","unstructured":"Abulizi M et al (2019)\u00a018F-Sodium fluoride PET\/MRI myocardial imaging in patients with suspected cardiac amyloidosis. J Nuc Cardiol: Official Pub Am Soc Nuclear Cardiol","DOI":"10.1007\/s12350-019-01885-8"},{"issue":"1","key":"10183_CR43","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12350-019-01675-2","volume":"28","author":"P Martineau","year":"2021","unstructured":"Martineau P et al (2021) Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis. Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology 28(1):209\u2013218","journal-title":"Journal of Nuclear Cardiology: Official Publication of the American Society of Nuclear Cardiology"},{"issue":"7","key":"10183_CR44","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2967\/jnumed.120.245381","volume":"61","author":"A Masri","year":"2020","unstructured":"Masri A et al (2020) Molecular imaging of cardiac amyloidosis. Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine 61(7):965\u2013970","journal-title":"Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine"},{"issue":"6","key":"10183_CR45","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jjcc.2020.07.003","volume":"76","author":"SH Kim","year":"2020","unstructured":"Kim SH, Kim YS, Kim S-J (2020) Diagnostic performance of PET for detection of cardiac amyloidosis: a systematic review and meta-analysis. J Cardiol 76(6):618\u2013625","journal-title":"J Cardiol"},{"issue":"1","key":"10183_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCRESAHA.115.305364","volume":"118","author":"DD Gutterman","year":"2016","unstructured":"Gutterman DD et al (2016) The human microcirculation: regulation of flow and beyond. Circ Res 118(1):157\u2013172","journal-title":"Circ Res"},{"issue":"4","key":"10183_CR47","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10741-017-9628-1","volume":"22","author":"PE Bravo","year":"2017","unstructured":"Bravo PE, Di Carli MF, Dorbala S (2017) Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies. Heart Fail Rev 22(4):455\u2013464","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10183_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrcardio.2014.160","volume":"12","author":"PG Camici","year":"2015","unstructured":"Camici PG, d\u2019Amati G, Rimoldi O (2015) Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 12(1):48\u201362","journal-title":"Nat Rev Cardiol"},{"key":"10183_CR49","doi-asserted-by":"crossref","unstructured":"Tsai SB et al (2011)\u00a0Myocardial infarction with \u201cclean coronaries\u201d caused by amyloid light-chain AL amyloidosis: a case report and literature review. Amyloid: The Int J Exp Clinical Investigation: The Official J Int Soc Amyloidosis\u00a018(3):160\u2013164","DOI":"10.3109\/13506129.2011.571319"},{"issue":"11","key":"10183_CR50","doi-asserted-by":"publisher","first-page":"838","DOI":"10.7326\/0003-4819-131-11-199912070-00007","volume":"131","author":"J Al Suwaidi","year":"1999","unstructured":"Al Suwaidi J et al (1999) Systemic amyloidosis presenting with angina pectoris. Ann Intern Med 131(11):838\u2013841","journal-title":"Ann Intern Med"},{"issue":"4","key":"10183_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/000331970105200407","volume":"52","author":"H Ogawa","year":"2001","unstructured":"Ogawa H et al (2001) Cardiac amyloidosis presenting as microvascular angina\u2013a case report. Angiology 52(4):273\u2013278","journal-title":"Angiology"},{"issue":"3","key":"10183_CR52","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/0002-9149(79)90389-8","volume":"44","author":"RR Smith","year":"1979","unstructured":"Smith RR, Hutchins GM (1979) Ischemic heart disease secondary to amyloidosis of intramyocardial arteries. Am J Cardiol 44(3):413\u2013417","journal-title":"Am J Cardiol"},{"issue":"7","key":"10183_CR53","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-9149(99)00879-6","volume":"85","author":"M Hongo","year":"2000","unstructured":"Hongo M et al (2000) Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings. Am J Cardiol 85(7):849\u2013853","journal-title":"Am J Cardiol"},{"issue":"8","key":"10183_CR54","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/eurheartj\/ehm066","volume":"28","author":"KM Modesto","year":"2007","unstructured":"Modesto KM et al (2007) Vascular abnormalities in primary amyloidosis. Eur Heart J 28(8):1019\u20131024","journal-title":"Eur Heart J"},{"key":"10183_CR55","doi-asserted-by":"crossref","unstructured":"Buja LM, Khoi NB, Roberts WC (1970) Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients. The Am J Cardiol\u00a026(4):94\u2013405","DOI":"10.1016\/0002-9149(70)90736-8"},{"issue":"4","key":"10183_CR56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jchf.2014.03.009","volume":"2","author":"S Dorbala","year":"2014","unstructured":"Dorbala S et al (2014) Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. JACC Heart failure 2(4):358\u2013367","journal-title":"JACC Heart failure"},{"issue":"4","key":"10183_CR57","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/13506129.2020.1798223","volume":"27","author":"K Takasone","year":"2020","unstructured":"Takasone K et al (2020) Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging. Amyloid 27(4):266\u2013274","journal-title":"Amyloid"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10183-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-021-10183-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-021-10183-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T08:23:48Z","timestamp":1660811028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-021-10183-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,7]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10183"],"URL":"https:\/\/doi.org\/10.1007\/s10741-021-10183-w","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,7]]},"assertion":[{"value":"14 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Additional declarations for articles in life science journals that report the results of studies involving humans and\/or animals"}}]}}